Call Us: 1.800.873.5297

By

Update of FDA’s Treatment of Acetaminophen

Beginning yesterday, the FDA gathered more than 35 experts in Maryland to discuss their options of how to prevent overdoses of over-the-counter acetaminophen. Acetaminophen is the pain and fever reducing active ingredient in drugs such as Tylenol and Excedrin. Acetaminophen overdose is the leading cause of liver failure in the United States. We reported in […]

By

Doctor Admits Giving Patients the Wrong Radiation Doses

A Philadelphia doctor, who has been accused of botching dozens of prostate cancer surgeries at a Veterans Administration hospital, admitted Monday that he sometimes missed his target when implanting radioactive seeds, leaving patients with incorrect dosages.Dr. Gary Kao said these mistakes are commonplace when you are aiming seeds at the walnut-sized prostate, which sits near […]

By

New Cancer Drug Has Been Very Effective in Animal Trials

A new method of attacking cancer cells, developed by researchers in Australia, has proved surprisingly effective in animal tests.The method is intended to sidestep two major drawbacks of standard chemotherapy: the treatment’s lack of specificity and the fact that cancer cells often develop resistance to treatment. The new method, called EnGeneIC, uses “minicells” to deliver […]

By

Accutane Pulled Off the Market after Jury Verdict

Roche Holding AG, one of biggest makers of cancer drugs, pulled its Accutane acne medicine from the U.S. market after juries awarded at least $33 million in damages to users who blamed the drug for bowel disease. Roche notified the FDA today that it would be withdrawing Accutane after a reevaluation of the product showed […]

By

CDC to Reinstate Booster Shots for Babies and Toddlers

The U.S. Center for Disease Control and Prevention (CDC) announced today that it plans to reinstate booster shots of the vaccine HiB (Haemphilus influenza type b) for babies and toddlers ages 12 to 15 months. The vaccine protects against bacterial meningitis. In 2007, Merck & Co. Inc. recalled its HiB vaccines due to the fact […]

By

Piroxicam Label in Canada to be Revised

On June 25, 2009, Health Canada, an organization similar to the FDA, announced new restrictions fro Piroxicam. The agency concluded that piroxicam should no longer be used to treat short-term pain and inflammation because of an increased risk of serious skin reactions and gastrointestinal problems relative to other similar drugs. Piroxicam is a prescription drug […]

By

Clot-Blocking Drug for Stroke Patients Advised Can be Used for Longer Period of Time than Originally Thought

The American Heart Association (AHA) released an advisory that a “clot-busting” drug can be effective for an extra 90 minutes longer than what the FDA has approved the drug for. The drug, called recombinant-tissue plasminogen activator, or rt-PA, is one that can be administered to stroke patients when they enter the hospital and will immediately […]

By

FDA Approves Generic Version of Plan B Emergency Contraceptive

Today the FDA approved the first generic version of Plan B, an emergency contraceptive tablet that contains 0.75 mg of Levonorgestrel. The generic product will only be available by prescription for women ages 17 and under. Plan B, which is manufactured by Duramed Pharmaceuticals Inc., was first approved in 1999. Women of all ages were […]

By

600 Neighborhoods Have Elevated Cancer Risks

According to new data released by the Environmental Protection Agency (EPA), people living in nearly 600 neighborhoods across the country are breathing concentrations of toxic air pollutions that put them at a much greater risk of contracting cancer. The levels of 80 cancer-causing substances released by automobiles, factories, and other sources, in these neighborhoods produce […]

By

Faulty Insurance Database Overcharged Patients for Healthcare

This week congressional investigators announced that two-thirds of the health insurance industry used a faulty database, which in turned cost patients when seeing doctors outside of the insurance network billions in inflated bills. The database operated by Ingenix, a subsidiary of UnitedHealth Group, agreed in January to pay $350 million to settle allegations that i […]

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.